CB1 antagonist 1
Modify Date: 2024-01-03 13:03:03
CB1 antagonist 1 structure
|
Common Name | CB1 antagonist 1 | ||
|---|---|---|---|---|
| CAS Number | 890037-68-0 | Molecular Weight | 461.39 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C26H22Cl2N4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of CB1 antagonist 1CB1 antagonist 1 is an antagonist of CB1 receptor, used in the research of metabolic syndrome and obesity, neuroinflammatory disorders, cognitive disorders and psychosis, gastrointestinal disorders, and cardiovascular conditions. |
| Name | CB1 antagonist 1 |
|---|
| Description | CB1 antagonist 1 is an antagonist of CB1 receptor, used in the research of metabolic syndrome and obesity, neuroinflammatory disorders, cognitive disorders and psychosis, gastrointestinal disorders, and cardiovascular conditions. |
|---|---|
| Related Catalog | |
| Target |
CB1[1] |
| In Vitro | CB1 antagonist 1 is an antagonist of CB1 receptor, used in the research of metabolic syndrome and obesity, neuroinflammatory disorders, cognitive disorders and psychosis, gastrointestinal disorders, and cardiovascular conditions[1]. |
| References |
[1]. Gilbert, Eric J, et al. SUBSTITUTED PIPERAZINES AS CB1 ANTAGONISTS. WO 2006060461 A1. |
| Molecular Formula | C26H22Cl2N4 |
|---|---|
| Molecular Weight | 461.39 |